نتائج البحث - Francisco Abad‐Santos

تنقيح النتائج
  1. 1
    Effect of thoracentesis on pulmonary gas exchange.

    Effect of thoracentesis on pulmonary gas exchange. حسب M. Perpiñá, Eduardo Benlloch, V. Marco, Francisco Abad‐Santos, D. Nauffal

    منشور في 1983
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    New Trends in Digital Technology-Based Psychological and Educational Assessment

    New Trends in Digital Technology-Based Psychological and Educational Assessment حسب Paula Elosua, David Aguado, Eduardo Fonseca‐Pedrero, Francisco Abad‐Santos, Pablo Santamaría

    منشور في 2023
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Impact of Genetic Variation in Adrenergic Receptors on β-Blocker Effectiveness and Safety in Cardiovascular Disease Management: A Systematic Review

    Impact of Genetic Variation in Adrenergic Receptors on β-Blocker Effectiveness and Safety in Cardiovascular Disease Management: A Systematic Review حسب Houwaida Abbes, Paula Soria‐Chacartegui, Asma Omezzine, Francisco Abad‐Santos, Pablo Zubiaur

    منشور في 2025
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Genetic Polymorphisms Associated With the Pharmacokinetics, Pharmacodynamics and Adverse Effects of Olanzapine, Aripiprazole and Risperidone

    Genetic Polymorphisms Associated With the Pharmacokinetics, Pharmacodynamics and Adverse Effects of Olanzapine, Aripiprazole and Risperidone حسب Paula Soria‐Chacartegui, Gonzalo Villapalos‐García, Pablo Zubiaur, Francisco Abad‐Santos, Dóra Koller

    منشور في 2021
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Genetics of Psoriasis and Pharmacogenetics of Biological Drugs

    Genetics of Psoriasis and Pharmacogenetics of Biological Drugs حسب Rocío Prieto‐Pérez, Teresa Cabaleiro, E. Daudén, Dolores Ochoa, Manuel Román, Francisco Abad‐Santos

    منشور في 2013
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Influence of <i><scp>CYP</scp>2D6</i>,<i><scp>CYP</scp>3A4</i>,<i><scp>CYP</scp>3A5</i> and <i><scp>ABCB</scp>1</i> Polymorphisms on Pharmacokinetics and Safety of Aripiprazole in Healthy Volunteers

    Influence of <i><scp>CYP</scp>2D6</i>,<i><scp>CYP</scp>3A4</i>,<i><scp>CYP</scp>3A5</i> and <i><scp>ABCB</scp>1</i> Polymorphisms on Pharmacokinetics and Safety of Aripiprazole in... حسب Carmen Belmonte, Dolores Ochoa, Manuel Román, Miriam Saiz‐Rodríguez, Aneta Wojnicz, Clara Gomez-Sanchez, Samuel Martín‐Vílchez, Francisco Abad‐Santos

    منشور في 2018
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Developments in pharmacogenetics, pharmacogenomics, and personalized medicine

    Developments in pharmacogenetics, pharmacogenomics, and personalized medicine حسب Francisco Abad‐Santos, Salvador F. Aliño, Alberto M. Borobia, Elena García‐Martín, Patricia Gassó, Olalla Maroñas, José A. G. Agúndez

    منشور في 2024
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Polymorphisms in <i>CYP1A2, CYP2C9</i> and <i>ABCB1</i> affect agomelatine pharmacokinetics

    Polymorphisms in <i>CYP1A2, CYP2C9</i> and <i>ABCB1</i> affect agomelatine pharmacokinetics حسب Miriam Saiz‐Rodríguez, Dolores Ochoa, Carmen Belmonte, Manuel Román, Danilo Vieira de Lara, Pablo Zubiaur, Dóra Koller, Gina Mejía‐Abril, Francisco Abad‐Santos

    منشور في 2019
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Effect of ABCB1 C3435T Polymorphism on Pharmacokinetics of Antipsychotics and Antidepressants

    Effect of ABCB1 C3435T Polymorphism on Pharmacokinetics of Antipsychotics and Antidepressants حسب Miriam Saiz‐Rodríguez, Carmen Belmonte, Manuel Román, Dolores Ochoa, Carolina Jiang‐Zheng, Dóra Koller, Gina Mejía‐Abril, Pablo Zubiaur, Aneta Wojnicz, Francisco Abad‐Santos

    منشور في 2018
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Effect of Polymorphisms on the Pharmacokinetics, Pharmacodynamics and Safety of Sertraline in Healthy Volunteers

    Effect of Polymorphisms on the Pharmacokinetics, Pharmacodynamics and Safety of Sertraline in Healthy Volunteers حسب Miriam Saiz‐Rodríguez, Carmen Belmonte, Manuel Román, Dolores Ochoa, Dóra Koller, María Talegón, María C. Ovejero‐Benito, Rosario López‐Rodríguez, Teresa Cabaleiro, Francisco Abad‐Santos

    منشور في 2017
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    Polymorphisms associated with fentanyl pharmacokinetics, pharmacodynamics and adverse effects

    Polymorphisms associated with fentanyl pharmacokinetics, pharmacodynamics and adverse effects حسب Miriam Saiz‐Rodríguez, Dolores Ochoa, Coral Herrador, Carmen Belmonte, Manuel Román, Enrique Alday, Dóra Koller, Pablo Zubiaur, Gina Mejía‐Abril, María Hernández‐Martínez, Francisco Abad‐Santos

    منشور في 2018
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    Effect of the Most Relevant CYP3A4 and CYP3A5 Polymorphisms on the Pharmacokinetic Parameters of 10 CYP3A Substrates

    Effect of the Most Relevant CYP3A4 and CYP3A5 Polymorphisms on the Pharmacokinetic Parameters of 10 CYP3A Substrates حسب Miriam Saiz‐Rodríguez, Susana Almenara, Marcos Navares‐Gómez, Dolores Ochoa, Manuel Román, Pablo Zubiaur, Dóra Koller, María Santos, Gina Mejía‐Abril, Alberto M. Borobia, Cristina Rodríguez‐Antona, Francisco Abad‐Santos

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    ROS induced mitochondrial hormesis partially protects from SGAs mitochondrial toxicity and cardiovascular disease

    ROS induced mitochondrial hormesis partially protects from SGAs mitochondrial toxicity and cardiovascular disease حسب Laura Doblado, Gaurangkumar Patel, Manuel Parrilla, Ramazan Yildiz, Leticia Selinger, Salvador Pérez, Sara Amor, Lucía Gómez, Dóra Koller, Antonio Martínez, Susana Cadenas, Juan Sastre, Francisco Abad‐Santos, Ángel Luis Garcı́a-Villalón, Miriam Granado, Marı́a Monsalve

    منشور في 2023
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  14. 14
    Consensus of experts from the Spanish Pharmacogenetics and Pharmacogenomics Society and the Spanish Society of Medical Oncology for the genotyping of DPYD in cancer patients who are candidates for treatment with fluoropyrimidines

    Consensus of experts from the Spanish Pharmacogenetics and Pharmacogenomics Society and the Spanish Society of Medical Oncology for the genotyping of DPYD in cancer patients who ar... حسب Pilar García‐Alfonso, Miriam Saiz‐Rodríguez, R. Mondéjar, Juliana Salazar, David Páez, Alberto M. Borobia, María José Safont, Irene García-García, Rámón Colomer, Xandra García‐González, Marí­a José Herrero, Luis A. López‐Fernández, Francisco Abad‐Santos

    منشور في 2021
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  15. 15
    First-in-human phase I clinical trial of a TLR4-binding DNA aptamer, ApTOLL: Safety and pharmacokinetics in healthy volunteers

    First-in-human phase I clinical trial of a TLR4-binding DNA aptamer, ApTOLL: Safety and pharmacokinetics in healthy volunteers حسب Macarena Hernández‐Jiménez, Samuel Martín‐Vílchez, Dolores Ochoa, Gina Mejía‐Abril, Manuel Román, Paola Camargo-Mamani, Sergio Luquero‐Bueno, Bernd Jilma, Marı́a A. Moro, Gerónimo Fernández, David Piñeiro, Marc Ribó, Vı́ctor M. González, Ignacio Lizasoaín, Francisco Abad‐Santos

    منشور في 2022
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  16. 16
    APRIL: A double-blind, placebo-controlled, randomized, Phase Ib/IIa clinical study of ApTOLL for the treatment of acute ischemic stroke

    APRIL: A double-blind, placebo-controlled, randomized, Phase Ib/IIa clinical study of ApTOLL for the treatment of acute ischemic stroke حسب Macarena Hernández‐Jiménez, Francisco Abad‐Santos, Ian A. Cotgreave, Jaime Gállego, Bernd Jilma, Alan Flores, Tudor Jovin, José Vivancos, Carlos A. Molina, Joan Montaner, Joaquín Casariego, Mads K. Dalsgaard, María Hernández‐Pérez, David S. Liebeskind, Erik Cobo, Marc Ribó

    منشور في 2023
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  17. 17
    Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort Study

    Combination of Tocilizumab and Steroids to Improve Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort Study حسب Belén Ruíz‐Antorán, Aránzazu Sancho‐López, Ferràn Torres, Víctor Moreno‐Torres, Itziar de Pablo-López, Paulina García-López, Francisco Abad‐Santos, Clara Rosso-Fernández, Ana Aldea‐Perona, Eva Montané, Ruth M. Aparicio-Hernández, Roser Llop-Rius, Consuelo Pedrós, Paloma Gijón, Carolina Hernández-Carballo, Maria Jose Pedrosa-Martinez, Consuelo Rodríguez‐Jiménez, Guillermo Prada-Ramallal, Lourdes Cabrera, Josefa Aguilar-García, Rocío Sanjuán‐Jiménez, E. Ortiz-Barraza, Enrique Sánchez-Chica, Ana Fernández‐Cruz

    منشور في 2020
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  18. 18
    Use of renin–angiotensin–aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study

    Use of renin–angiotensin–aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study حسب Francisco J. de Abajo, Sara Rodríguez‐Martín, Victoria Lerma, Gina Mejía‐Abril, Mónica Aguilar, Amelia García-Luque, Leonor Laredo, Olga Laosa, Gustavo Adolfo Centeno-Soto, María A. Gálvez, Miguel Puerro, Esperanza González‐Rojano, Laura Pedraza, Itziar de Pablo, Francisco Abad‐Santos, Leocadio Rodríguez‐Mañas, Miguel Gil, Aurelio Tobı́as, Antonio Rodríguez, Diego Rodrı́guez-Puyol, Diana Barreira‐Hernández, Pablo Zubiaur, Elena Santos-Molina, Elena Pintos-Sánchez, Marcos Navares‐Gómez, Rubén Aparicio, V. García-Rosado, Carlos Gutiérrez-Ortega, Carlos A. Perez, Ana Ascaso, Carlos Lerma

    منشور في 2020
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  19. 19
    Genetic variants regulating the immune response improve the prediction of COVID-19 severity provided by clinical variables

    Genetic variants regulating the immune response improve the prediction of COVID-19 severity provided by clinical variables حسب Pablo Delgado‐Wicke, Sara Fernández de Córdoba‐Oñate, Emilia Roy‐Vallejo, Estíbaliz Alegría‐Carrasco, Diego Aníbal Rodríguez-Serrano, Amalia Lamana, Núria Montés, Ana Nicolao-Gómez, Rosa Carracedo-Rodríguez, Ana Marcos‐Jiménez, Paula Díaz-Fernández, José María Galván‐Román, Laura Rabes-Rodríguez, Marta Sanz-Alba, Jesús Álvarez-Rodríguez, Almudena Villa-Martí, Carlos Rodríguez-Franco, Gonzalo Villapalos‐García, Pablo Zubiaur, Francisco Abad‐Santos, Ignacio De Los Santos, Rosa P. Gomariz, Rosario García‐Vicuña, Cecilia Muñoz‐Calleja, Isidoro González‐Álvaro, Elena Fernández-Ruíz

    منشور في 2024
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  20. 20
    Strategies to design clinical studies to identify predictive biomarkers in cancer research

    Strategies to design clinical studies to identify predictive biomarkers in cancer research حسب Jose Luis Pérez‐Gracia, Miguel F. Sanmamed, Ana Bosch, Ana Patiño‐García, Kurt A. Schalper, Víctor Segura, Joaquim Bellmunt, Josep Tabernero, Christopher J. Sweeney, Toni K. Choueiri, Miguel Martín, Juan P. Fusco, María E. Rodríguez-Ruiz, Alfonso Calvo, Celia Prior, Luis Paz‐Ares, Rubén Pı́o, Enrique González‐Billalabeitia, Álvaro González Hernández, David Páez, Josep M. Piulats, Alfonso Gúrpide, Mapi Andueza, Guillermo de Velasco, Roberto Pazo, Enrique Grande, Pilar Nicolás, Francisco Abad‐Santos, Jesús García-Donás, Daniel Castellano, María J. Pajares, Cristina Suárez, Rámón Colomer, Luis M. Montuenga, Ignacio Melero

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: